During the past decade, Tokyo Metropolitan Police Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokyo Metropolitan Police Hospital" #1 sponsor was "Bayer" with 1 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Janssen Pharmaceutical K.K." with 1 trials sponsored, "Society for Advancement of Coronary Intervention Research" with 1 trials sponsored and "The PCI Guideline Research Society" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Metropolitan Police Hospital" #1 collaborator was "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Metropolitan Police Hospital" are "COVID-19" (1 trials), "Cancer" (1 trials), "Coronary Artery Disease" (1 trials), "Jaundice" (1 trials) and "Long Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Tokyo Metropolitan Police Hospital" in a lesser frequency.

Most popular intervention types in "Tokyo Metropolitan Police Hospital" are "Drug" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Androgen-deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Bicalutamide" (1 trials) and "Biliary drainage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Metropolitan Police Hospital" are 4 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Tokyo Metropolitan Police Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tokyo Metropolitan Police Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Metropolitan Police Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".